Skip to main content
. Author manuscript; available in PMC: 2018 Jan 28.
Published in final edited form as: AIDS. 2017 Jan 28;31(3):355–364. doi: 10.1097/QAD.0000000000001312

Figure 2.

Figure 2

Percentage not suppressed (a,c) and median area under the viral load curve (AUVLC) (b,d) at intervals between scheduled trial visits in Cohort C.2 and Cohort D, respectively, by age at antiretroviral therapy (ART) initiation (<6 months vs. 6–24 months)